Feedback    Advertise    Submit Papers    Reprints    About    Help    Contact   
Upstream Processing Downstream Processing Manufacturing Analytical Facilities
Archive by Issue Archive by Article Type Supplements
CMC Forum Press Releases
Formulation and Fill for a Vaccine with Alum Adjuvant
Chris Aytug
BioProcess International, Vol. 8, No. 7, July–August 2010, p. 21
 



The goal: Develop a CGMP formulation–fill process for a subunit vaccine–aluminum adjuvant complex.

The challenge: To engineer a scaled-up process for vaccine–adjuvant suspension formulation and fill, ensuring a uniform fill per dose as well as a sterile product.

The outcome: Florida Biologix scientists successfully developed the manufacturing, formulation–fill process and test methods. The process was conducted successfully in a scaled-down engineering run and at full scale, and 2,500 vials were tested, released, and shipped to the clinic on time.

About Florida Biologix

Aseptic fill is only one small part of our business. Florida Biologix is a phase 1–2 biologics development, manufacturing, and testing organization that offers a wide range of services to the biotechnology industry. FB will overcome scientific challenges with scalable solutions for phase 1–2 and beyond; provide exceptional customer service with clear and honest communication; and ensure client manufacturing process ownership of high-quality GMP products. You can trust us to develop, produce, test, and/or fill CGMP-compliant biopharmaceutical clinical trial material on time and at an outstanding value.

A Full Range of Services in a State-of-the-Art Facility

FB Services Include

  • cell line engineering and CGMP cell banking

  • upstream and downstream processes design

  • QC assay development and qualification

  • CGMP production/purification of proteins expressed in mammalian cells (MAbs, recombinant proteins, enzymes, vaccines, other biomolecules)

  • aseptic filling (nonhazardous small molecules, nucleic acids, proteins)

  • product characterization and testing

  • regulatory support.

Our 23,000-ft2 GMP multiproduct facility was designed and built with best-in-class equipment to provide timely, low-cost, high-quality, CGMP-compliant products. Our product development labs are in the adjacent building.



Individual Attention from an Experienced Team

Our people are not only deeply experienced in biopharmaceutical manufacturing and testing, but we are also approachable, trustworthy, and believe that the best way to build long-term relationships with our clients is through open communication. We know what it takes to get a product into the clinic and eventually to market. This explains why 95% of our clients say they would work with us again or refer us to others.

Highest quality at a Competitive Price

Quality is paramount in our business, and you will find it at every level of our organization. In-house quality control and quality assurance means your product will be appropriately characterized, tested, and released. Our operational model, location, and affiliations keep costs low — and we pass this savings to you.

Author Details
Chris Aytug is director of marketing and sales at Florida Biologix, 13702 Innovation Drive, Alachua, FL 32615; 877-765-7676; caytug@floridabiologix.ufl.com; www.floridabiologix.ufl.com.

 
| | Share
Biopharmaceutical Production
Facility Design Strategies for Single-Use Technologies

Please join us for a free webinar addressing strategies for facility design in biopharmaceutical manufacturing:

Wednesday, 29 February 2012
8:00 AM and 1:00 PM EST

Presented by:

Ingrid Long, MSc
Research Engineer
GE Healthcare Life Sciences

Register today!

During the webinar, Ms. Long will discuss the impact of different strategies for facility design, with a focus on the following topics:

* Replacement of traditional equipment with the single-use equivalent
* Biopharmaceutical manufacturing in a single room
* Benefits of facility design with respect to cost, risk, and flexibility

Register today!


Nine Conferences — One Location: Hilton Bayfront (San Diego, CA)
Webinars   
Subscribe   
Reprints   
Contact   
About   
Informa plc
©2002 - 2009 BioProcess International
Ph: 508-616-5550